Skip to main content
ACCURAY INC logo

ACCURAY INC — Investor Relations & Filings

Ticker · ARAY ISIN · US0043971052 LEI · 549300G28LY4TZKZJG51 US Manufacturing
Open in API
Filings indexed 1,204 across all filing types
Latest filing 2026-06-04 Capital/Financing Update
Country US United States of America
Listing US ARAY

About ACCURAY INC

https://www.accuray.com/

Accuray Incorporated is a radiation therapy company that designs, develops, manufactures, and sells advanced systems for cancer treatment. Its key products include the CyberKnife® S7™ System and the Radixact® System. The CyberKnife system is a robotic platform that delivers non-invasive stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) with high precision, utilizing AI-driven, real-time motion synchronization. The Radixact System provides image-guided intensity-modulated radiation therapy (IG-IMRT) and 3D conformal radiation therapy (3DCRT). Accuray's solutions are engineered to treat a broad range of tumors throughout the body, aiming to enhance clinical outcomes, improve quality of life, and streamline treatment workflows for healthcare providers in radiation oncology and neurosurgery.

Recent filings

Filing Released Lang Actions
FORM 8-K
Capital/Financing Update Classification · 90% confidence The document is a Form 8-K current report filed under the Securities Exchange Act, specifically Item 1.02 covering the termination of a material definitive agreement — full repayment and discharge of 3.75% Convertible Senior Notes due 2026. This describes a financing activity and capital structure change rather than an earnings release, management discussion, or proxy material. Therefore, it is best classified as a Capital/Financing Update.
2026-06-04 English
FORM SD
Regulatory Filings Classification · 95% confidence The document is a SEC Form SD (Specialized Disclosure Report) filed under Rule 13p-1 for Conflict Minerals Disclosure. It does not contain substantive financial statements or serve as an earnings or annual report, but is a compliance/regulatory disclosure filing. There is no dedicated code for Form SD or conflict minerals, so it falls into the general Regulatory Filings category.
2026-05-29 English
FORM S-8
Regulatory Filings Classification · 88% confidence The document is a SEC Form S-8 registration statement (a compliance filing under the Securities Act of 1933) used to register shares for employee benefit plans. It does not contain financial statements or management discussion, nor is it an earnings release, proxy, or other specialized report. It is a regulatory compliance filing and therefore falls into the fallback category “Regulatory Filings (RNS).”
2026-05-29 English
8-K - ACCURAY INC (0001138723) (Filer)
Regulatory Filings Classification · 88% confidence The document is a U.S. SEC Form 8-K (“Current Report”) furnishing an earnings press release (Exhibit 99.1) and investor presentation (Exhibit 99.2) under Items 2.02 and 7.01. It does not itself contain comprehensive financial statements or detailed management discussion, nor is it simply a presentation or earnings release standalone; it is a regulatory compliance filing under the Exchange Act. Accordingly, it should be classified as a general Regulatory Filing (RNS).
2026-05-06 English
8-K - ACCURAY INC (0001138723) (Filer)
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated April 26, 2026, reporting the departure of a senior executive (Senior Vice President, Chief Operations Officer). The key section is Item 5.02, which specifically addresses the departure of directors or certain officers. There is no financial data or report attached, and the document is relatively short (3196 characters). This type of filing is a management change announcement rather than a financial report or other category. Therefore, the appropriate classification is Board/Management Information (MANG).
2026-04-28 English
8-K - ACCURAY INC (0001138723) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The content describes an amendment to a consulting agreement involving a board member, including changes to compensation and equity vesting terms. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is primarily an announcement of a material definitive agreement amendment, which fits the category of a Regulatory Filing (RNS) as it does not fall under more specific categories like MANG or CAP. The document length is 4606 characters, which is relatively short and consistent with a regulatory announcement rather than a full report.
2026-04-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.